Drug Profile
Nitrullyn
Alternative Names: CRC 7805068Latest Information Update: 03 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malignant melanoma; Non-small cell lung cancer; Small cell lung cancer